Conclusion
Most of the work and interest in CEUS has been focused on the liver, and therefore this technique has been established as a reliable tool for detection and characterization of liver lesions. However, microbubbles are distributed within the blood and appear wherever there is blood supply. The properties of Sono Vue and the high sensitivity of recent ultrasound equipment to the presence of microbubbles have shown that CEUS is potentially very useful in many organs and vascular structures. During the study of new possible applications of this technique, we found areas where CEUS, in selected cases, contributes significantly towards the diagnosis. Of these, the field of parenchymal trauma may at present be one of the most promising applications deserving more extensive study with the prospect of giving CEUS a central part in standard trauma procedures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Solbiati L, Martegani A, Leen E, Correas JM, Burns PN, Becker D (2003) Contrast enhanced ultrasound of liver diseases. Springer-Verlag
Leen E, Horgan P (2003) Ultrasound contrast agents for hepatic imaging with nonlinear modes. Curr Probl Diagn Radiol Mar-Apr; 32(2):66–87
Lencioni R, Cioni D, Crocetti L, Donati F, Franchini C, Giusti S, Bartolozzi C (2002) Ultrasound imaging of focal liver lesions with a second-generation contrast agent. Acad Radiol Aug; 9 Suppl 2:S371–4
Bauer A, Solbiati L, Weissman N (2002) Ultrasound imaging with Sono Vue: low mechanical index real-time imaging. Acad Radiol Aug; 9 Suppl 2: S282–4
Quaia E, Stacul F, Bertolotto M, Locatelli M, Mucelli RP (2002) Characterization of focal liver lesions with pulse inversion harmonic imaging (PIHI) using a second generation US contrast agent. Acad Radiol Aug; 9 Suppl 2:S376–9
Leen E, Angerson WJ, Yarmenitis S, Bongartz G, Blomley M, Del Maschio A, Summaria V, Maresca G, Pezzoli C, Llull JB (2002) Multi-centre clinical study evaluating the efficacy of Sono Vue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol Mar; 41(3):200–6
Basilico R, Blomley MJ, Harvey CJ, Filippone A, Heckemann RA, Eckersley RJ, Cosgrove DO (2002) Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent? Eur J Radiol Mar; 41(3):184–91
Leen E (2001) The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 11 Suppl 3: E27–34. Review
Solbiati L, Tonolini M, Cova L, Goldberg SN (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11 Suppl 3: E15–26. Review
Spinazzi A (2001) Emerging clinical applications for contrast-enhanced ultrasonography. Eur Radiol 11 Suppl 3:E7–12. Review
Schneider M, Arditi M, Barrau M, Brochot J, Broillet A, Ventrone R, Yan F (1995) BR1, A new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbles. Invest Radiol 30:451–457.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thorelius, L. Contrast-enhanced ultrasound: beyond the liver. Eur Radiol 13 (Suppl 3), N91–N108 (2003). https://doi.org/10.1007/s00330-003-0014-0
Issue Date:
DOI: https://doi.org/10.1007/s00330-003-0014-0